Who cares? Teva said t-enox facilities had been inspected and had presumably passed, according to Ms. Chen. I fail to see the consequence of whose facilities they are.
If you hypothetically knew that Teva’s Lovenox were some other company’s drug and that Teva were merely a marketing arm, it wouldn’t affect your assessment of this drug’s approvability? I find your statement astonishing.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”